The Technical AnalystExchange: SHZ Sector: Healthcare Industry: Drug Manufacturers—Specialty & Generic
Shandong Shanda Wit Price, Forecast, Insider, Ratings, Fundamentals & Signals
0.06% CNY35.74
America/New_York / 30 apr 2024 @ 03:04
| FUNDAMENTALS | |
|---|---|
| MarketCap: | 8 374.99 mill |
| EPS: | 2.52 |
| P/E: | 14.18 |
| Earnings Date: | Aug 12, 2024 |
| SharesOutstanding: | 234.33 mill |
| Avg Daily Volume: | 3.41 mill |
| RATING 2024-04-30 |
|---|
| A+ |
| Strong Buy |
| RATINGS | ||
|---|---|---|
| Rating CashFlow: | Strong Buy | |
| Return On Equity: | Strong Buy | |
| Return On Asset: | Strong Buy | |
| DE: | Neutral | |
| P/E: | Neutral | |
| Price To Book: | Buy |
| QUARTER GROWTHS | ||||||
|---|---|---|---|---|---|---|
| 4/22 | 1/23 | 2/23 | 3/23 | 4/23 | 1/24 | |
| Revenue | ||||||
| Gr.Profit | ||||||
| Ebit | ||||||
| Asset | ||||||
| Debt |
| PE RATIO: COMPANY / SECTOR |
|---|
| 0.40x |
| Company: PE 14.18 | sector: PE 35.84 |
| PE RATIO: COMPANY / INDUSTRY |
|---|
| 0.31x |
| Company: PE 14.18 | industry: PE 45.57 |
| DISCOUNTED CASH FLOW VALUE |
|---|
|
CNY83.90 (134.74%) CNY48.16 |
| Date: 2024-05-05 |
| Expected Trading Range (DAY) |
|---|
|
CNY 34.91 - 36.57 ( +/- 2.33%) |
| ATR Model: 14 days |
Live Trading Signals (every 1 min)
10.00
Buy
Last version updated: Fri April 15th, 2022
| Indicator Signals | |
|---|---|
| RSI 21 | |
| SMA | |
| Trend | |
| Trend 2 | |
| Trend 3 | |
| MACD |
| Volume Signals | |
|---|---|
| Price | CNY35.74 (0.06% ) |
| Volume | 2.49 mill |
| Avg. Vol. | 3.41 mill |
| % of Avg. Vol | 72.91 % |
| Signal 1: | |
| Signal 2: |
Today
Last 12 Months
RSI
Last 10 Buy & Sell Signals For 000915.SZ
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
| Date | Signal | @ | Closed | % |
|---|
000915.SZ
Shandong Shanda Wit Science and Technology Co., Ltd. engages in the pharmaceutical and environment protection businesses in China. Its medical products include azithromycin granules, glycyrrhiza zinc granules, compound calcium carbonate, vitamin AD drops, epalrestat tablets, valsartan hydrochlorothiazide gums, roxithromycin, rosiglitazone tartrate tablets, and glimepiride tablets. The company offers environmental products, including deep disc filters, sulfuric acid diluents, industrial wastewater treatment solutions, chlorine dioxide generators, chlorine dioxide purifiers, and flue gas desulfurization and denitrification emission technology, as well as plans and constructs artificial wetland. Its environmental products also comprise optional equipment and raw materials; chlorine dioxide disinfectants, compounds, and composites; waste gas treatment; and solid waste treatment. The company also provides information products, such as DLP splicing display units, LCD splicing display units, image stitching processors, industrial automation control products, and communication products; and crystal products. In addition, it is involved in the provision of education services. The company was founded in 1993 and is based in Jinan, China.